5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.67%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.16%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-18.75%
Negative EBIT growth while STERV.HE is at 10.75%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-18.75%
Negative operating income growth while STERV.HE is at 10.75%. Joel Greenblatt would press for urgent turnaround measures.
-51.01%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-46.67%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-46.67%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-8.14%
Share reduction while STERV.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-8.14%
Reduced diluted shares while STERV.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
65.77%
Positive OCF growth while STERV.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
266.79%
Positive FCF growth while STERV.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-23.89%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-27.08%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-30.20%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
30.50%
10Y OCF/share CAGR at 50-75% of STERV.HE's 45.96%. Martin Whitman might fear a structural deficiency in operational efficiency.
540.99%
5Y OCF/share CAGR above 1.5x STERV.HE's 93.88%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
103.03%
3Y OCF/share CAGR 1.25-1.5x STERV.HE's 76.55%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
133.33%
Net income/share CAGR 1.25-1.5x STERV.HE's 90.15%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
-31.58%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
150.00%
3Y net income/share CAGR above 1.5x STERV.HE's 55.00%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-2.03%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-7.88%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.50%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-4.03%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.55%
Positive asset growth while STERV.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
9.74%
Positive BV/share change while STERV.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-0.18%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-17.61%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.